Trial Profile
A Phase 1, Open-Label, 4-Way Crossover Regional Drug Absorption Study to Assess the Bioavailability of ASP015K in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Sep 2011
Price :
$35
*
At a glance
- Drugs Peficitinib (Primary) ; Peficitinib (Primary)
- Indications Plaque psoriasis; Transplant rejection
- Focus Pharmacokinetics
- 09 Sep 2011 New trial record